Patents by Inventor Beate Schmitz

Beate Schmitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Salt polymorph of thioxanthene-9-ylidene-1-methyl piperidine acid addition salts as antimigraine compounds
    Patent number: 9708304
    Abstract: The present invention relates to novel crystal forms of 4-(6-ethoxy-1-methoxy-thioxanthene-9-ylidene)-1-methyl piperidine salts and 4-(6-ethoxy-1-hydroxy-thioxanthene-9-ylidene)-1-methyl piperidine salts; especially to novel crystal forms of 4-(6-ethoxy-1-methoxy-thioxanthene-9-ylidene)-1-methyl piperidine hydrochloride and 4-(6-ethoxy-1-hydroxy-thioxanthene-9-ylidene)-1-methyl piperidine hydrochloride as well as to the use of these salts for preventing or treating migraine or pulmonary hypertension.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: July 18, 2017
    Assignee: Biofrontera Bioscience GmbH
    Inventors: Beate Schmitz, Hermann Luebbert
  • SALT POLYMORPH OF THIOXANTHENE-9-YLIDENE-1-METHYL PIPERIDINE ACID ADDITION SALTS AS ANTIMIGRAINE COMPOUNDS
    Publication number: 20150376168
    Abstract: The present invention relates to novel crystal forms of 4-(6-ethoxy-1-methoxy-thioxanthene-9-ylidene)-1-methyl piperidine salts and 4-(6-ethoxy-1-hydroxy-thioxanthene-9-ylidene)-1-methyl piperidine salts; especially to novel crystal forms of 4-(6-ethoxy-1-methoxy-thioxanthene-9-ylidene)-1-methyl piperidine hydrochloride and 4-(6-ethoxy-1-hydroxy-thioxanthene-9-ylidene)-1-methyl piperidine hydrochloride as well as to the use of these salts for preventing or treating migraine or pulmonary hypertension.
    Type: Application
    Filed: January 31, 2014
    Publication date: December 31, 2015
    Inventors: Beate SCHMITZ, Hermann LUEBBERT
  • 9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension
    Publication number: 20060120972
    Abstract: Pimethixene is used as a medicament for the treatment of pulmonary hypertension.
    Type: Application
    Filed: October 21, 2005
    Publication date: June 8, 2006
    Inventors: Peter Engels, Beate Schmitz
  • Multiple genes relevant for the characterization, diagnosis, and manipulation of neuropathic pain
    Publication number: 20030216341
    Abstract: The present invention relates to the use of differentially expressed polynucleotide sequences or polypeptides for the characterization of pain status or progression, a method for characterizing pain, a method for identifying therapeutic agents for pain and the use of such sequences for the development of a medicament.
    Type: Application
    Filed: February 14, 2003
    Publication date: November 20, 2003
    Inventors: Hermann Lubbert, Peter Engels, Beate Schmitz
  • Cathepsin Y for the development of a medicament for the treatment of pain
    Publication number: 20030212003
    Abstract: The present invention relates to the use of a polynucleotide sequence encoding Cathepsin Y or a amino acid sequence of Cathepsin Y protein for the characterization or identification of therapeutic agents for pain, the use of such sequences for the development of a medicament, and agents useful as medicaments for the treatment of pain.
    Type: Application
    Filed: February 14, 2003
    Publication date: November 13, 2003
    Inventors: Hermann Lubbert, Peter Engels, Beate Schmitz